FDA Approves New Treatments for Three Cancer Types
In November and the first half of December, the U.S. Food and Drug Administration (FDA) announced three approvals for...
Category: In the News
In November and the first half of December, the U.S. Food and Drug Administration (FDA) announced three approvals for...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
Each month, the editors from the portfolio of scientific journals published by the American Association for Cancer Research (AACR)...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held this year at the Hynes Convention Center in...
On Wednesday, the U.S. Food and Drug Administration (FDA) expanded the use of the molecularly targeted therapeutic niraparib (Zejula)...
Since its inception in 1993, the American Association of Cancer Research (AACR) Grants Program, in partnership with other nonprofit...
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Policy plays a critical role in the fight against cancer, influencing the funding of cancer research and driving the...